Binswanger's Disease (Subcortical arteriosclerotic encephalopathy)
NeuroLearn NeuroHelp Vascular @
Background Neuroimaging Gross Pathology Histopathology & Immunohistochemistry Differential Diagnosis Reference
BACKGROUND AND CLINICAL INFORMATION:
Head
Clinical features: Binswanger's disease is a form of vascular
dementia frequently present with hypertension, dementia, a pseudobulbar state, a
gait disorder often of Parkinsonian type, transient ischemic attack, and
multiple strokes. Patients with hypercoagulatory state have also been described
recently.
Clinical
diagnostic criteria:
[Bennett DA et al.]
Dementia
must be established by clinical examination and confirmed by neuropsychological
tests.
One finding from two of the following three groups must be present:
the
presence of a vascular risk factor or evidence of systemic vascular disease
evidence
of focal cerebrovascular disease
evidence
of "subcortical" cerebral dysfunction
Bilateral leukoaraiosis on CT or subcortical T2 weighed lesions larger than 2 X
2 mm on MRI
These
criteria lose their validity in the presence of multiple or bilateral cortical
lesions on imaging or severe dementia (e.g. MMS <10).
Comment: clearly, these criteria do not
exclude CADASIL!
Diagnosis: Binswanger's disease is a clinicopathologic
diagnosis. A clinical diagnosis can be made with these criteria. For pathologic
diagnosis, typical histology must be present and a clinical history of dementia
must be established before a definitive diagnosis of Binswanger's disease is
made. Cases without a well established clinical history of dementia are only
"consistent with Binswanger's disease".
Genetics: can be sporadic or familial.
Possible
etiologies:
Hypertension.
Ischemia.
Vasculopathy
including abnormal blood brain barrier and degeneration of the media
associated with depositions of collagens type I, III, IV, V and possibly
type VI, and other components of extracellular matrix.
Hypercoagulation:
significant elevation in levels of thrombin-antithrombin complex,
prothrombin fragment 1+2, and cross-linked D-dimer have been reported in
patients with Binswanger's disease.
Binswanger
disease has been associated with a particular radiologic appearance that
reflects the confluence of areas of white matter changes. Leukoareosis is a term
used to described the less intense appearance of periventricular tissues in
chronically hypertensive patients. Although frequently seen in Binswanger's
disease; leukoareosis, however, is not sufficient to make the diagnosis.
Brain weight is usually within normal
limits.
Marked atherosclerosis of the major cerebral arteries, enlarged lateral
ventricles, and shrunken white matter are usually the most prominent features.
Extensive softening of white matter extending from the ventricles to
the subcortical white matter. The hemispheric white matter are discoloured,
rubbery and firm, sprinkled with foci of infarction. The cerebral hemispheres
are affected and show frontal or parieto-occipital accentuation in some cases.
The cerebellum is usually not affected. A sponge like cut surface can be seen.
Cribiform changes: White matter shows ‚tat cribl‚ and gray matter show ‚tat lucanaire. These changes are not specific for Binswanger's disease and can be seen in brains of eldery hypertensive patients, vascular dementia with multiple infarcts and in dementia with evidence of both Alzheimer's disease and vascular disease.
HISTOPATHOLOGY AND IMMUNOHISTOCHEMISTRY:
Head
Myelin loss is marked, extensive, diffuse, and often
symmetrical. The subcortical U-fibers are characteristically preserved. There is
a variable amount of reactive astrocytosis. The number of oligodendrocytes is
reduced. Except in the recetly infarcted areas, macrophages are uncommon.
Multiple
small infarcts are noted in white and deep gray matter.
Cerebral cortex is usually preserved.
Axonal disruption: The most severely demyelinated zones shade into
areas of frank necrosis with axonal disruption best demonstrated by
immunostaining for neurofilament and silver stains. Reduction in axonal density
is also noted outside the areas of infarction.
CADASIL (See the chapter on CADASIL).
MELAS: clinical presentation, in particular age of onset
and muscle pathology, and genetic studies are very helpful.
Bennett DA et al. J Neurol Neurosurg Psychiat 1990 53:961.
NeuroLearn NeuroHelp Vascular For Comment: KarMing-Fung@ouhsc.edu
Background Neuroimaging Gross Pathology Histopathology & Immunohistochemistry Differential Diagnosis Reference